This content is from: Premium Biopharma Funds Regain Some Health At least one fund is in the black, and several others moved closer to breakeven in October. By Stephen Taub November 17, 2022
This content is from: Culture The Two Delivering Alpha Pitches That Made Stocks Jump Alexander Denner and Samantha Greenberg shared their top investment picks Wednesday at the hedge fund conference. Markets noticed. By Alicia McElhaney July 18, 2018
This content is from: Research The 2014 All-America Research Team: Biotechnology, No. 2: Geoffrey Meacham October 07, 2014
This content is from: Premium Icahn Alum Alex Denner Thrives on Popping Drug Stocks Sarissa Capital Management is one of the top performing activists so far this year. By Stephen Taub November 10, 2017
This content is from: Premium Inside Sarissa’s Healthy Returns Why the Tiger Cub and Icahn alum is outperforming other health-care funds. By Stephen Taub July 19, 2021
This content is from: Premium ValueAct Identifies Possible New Activist Target The hedge fund firm also revealed another small new position. By Stephen Taub February 21, 2017
